Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS). A small number of CIDP patients harbors autoantibodies against nodal/paranodal proteins, such as neurofascin 155 (NF155), contactin 1, and contactin-associated...

Full description

Bibliographic Details
Main Author:	Jun-ichi Kira
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Neurology
Subjects:	chronic inflammatory demyelinating polyneuropathy combined central and peripheral demyelination neurofascin 155 node of Ranvier IgG4
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.665136/full

Similar Items

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies
by: Laurent Bailly, et al.
Published: (2018-12-01)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
by: Syed Bukhari, et al.
Published: (2020-11-01)

Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?
by: Navnika Gupta, et al.
Published: (2022-08-01)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
by: Jan-Markus Diederich, et al.
Published: (2018-03-01)

Implication of Contactins in Demyelinating Pathologies
by: Ilias Kalafatakis, et al.
Published: (2021-01-01)

Chronic inflammatory demyelinating polyradiculoneuropathy with antineurofascin-155 antibodies: A first case report in Peru
by: Darwin Segura-Chávez, et al.
Published: (2023-01-01)

Clinical heterogeneity of anti⁃neurofascin 155 antibody positive paranodopathy
by: CHEN Hai, et al.
Published: (2022-04-01)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)

Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy
by: Haruki Koike, et al.
Published: (2020-05-01)

Different binding and pathogenic effect of neurofascin and contactin–1 autoantibodies in autoimmune nodopathies
by: Katharina Hecker, et al.
Published: (2023-06-01)

Childhood subacute inflammatory demyelinating polyneuropathy
by: Chia-Yu Hsu, et al.
Published: (2011-11-01)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
by: Jean-Michel Vallat, et al.
Published: (2022-04-01)

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy
by: Kamel Mahmoud Ali Hewedi, et al.
Published: (2020-06-01)

Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report
by: Chulmin Park, et al.
Published: (2023-03-01)

Depression with chronic inflammatory demyelinating polyneuropathy
by: Arun Marwale, et al.
Published: (2018-01-01)

Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
by: Lijun Wang, et al.
Published: (2022-11-01)

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)

Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies
by: Wanyu Wang, et al.
Published: (2022-09-01)

Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)

Atypical pure sensory forms of chronic inflammatory demyelinating polyneuropathies
by: Eugen Gavriliuc, et al.
Published: (2019-06-01)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)

A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
by: Karissa L. Gable, et al.
Published: (2022-08-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
by: Chafké Belmokhtar, et al.
Published: (2019-03-01)

Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey
by: Yu Hashimoto, et al.
Published: (2018-11-01)

PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)

Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy
by: N. B. Vuytsik, et al.
Published: (2017-02-01)

mTORC1 Activation by Loss of Tsc1 in Myelinating Glia Causes Downregulation of Quaking and Neurofascin 155 Leading to Paranodal Domain Disorganization
by: Qian Shi, et al.
Published: (2018-07-01)

Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
by: Ivo Bozovic, et al.
Published: (2023-08-01)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
by: Tomohiro Hayashi, et al.
Published: (2021-05-01)

Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—<i>A Systematic Review</i>
by: Elena-Sonia Moise, et al.
Published: (2022-07-01)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a Patient with Diabetes: a primary care perspective
by: Jordan Dever, et al.
Published: (2020-10-01)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
by: Rajabally YA, et al.
Published: (2020-09-01)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
by: Farzad Fatehi, et al.
Published: (2013-01-01)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
by: Yunfei Bai, et al.
Published: (2023-03-01)

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective
by: Dario Cocito, et al.
Published: (2023-11-01)

Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)

Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy
by: Babita Gupta, et al.
Published: (2011-01-01)

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)